|
HS Code |
298908 |
| Iupac Name | 3-Methyl(E)-7-[3-(4-Fluorophenyl)-1-methylethyl-indol-2-yl]-3-hydroxy-5-oxohept-6-enoate |
| Molecular Formula | C27H28FNO4 |
| Molecular Weight | 449.51 g/mol |
| Appearance | Solid (presumed, based on chemical class) |
| Solubility | Insoluble in water, soluble in organic solvents (predicted) |
| Purity | Varies depending on synthesis, typically >98% |
| Storage Conditions | Store at 2-8°C, protect from light and moisture |
| Smiles | CC(C)c1c(c2ccccc2n1)C=C(CCC(=O)O)C(=O)CC(C)=C(F)c3ccc(cc3) |
As an accredited 3-Methyl(E)-7-[3-(4-Fluorophenyl)-1-Methylethyl-Indol-2-Yl]-3-Hydroxy-5-Oxohept-6-Enoate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | The 50mg chemical is packaged in a sealed amber glass vial, labeled with compound name, CAS number, molecular formula, and storage instructions. |
| Shipping | This chemical is shipped in tightly sealed, chemically resistant containers to prevent leaks and contamination. It is packaged according to regulatory guidelines, including proper labeling and documentation. Shipping occurs via specialized carriers under controlled conditions, with temperature stability and cushioning to protect the substance from physical and environmental hazards during transit. |
| Storage | Store **3-Methyl(E)-7-[3-(4-Fluorophenyl)-1-Methylethyl-Indol-2-Yl]-3-Hydroxy-5-Oxohept-6-Enoate** in a tightly sealed container, protected from light and moisture. Keep at 2–8 °C (refrigerated) in a well-ventilated, cool, and dry environment. Avoid sources of ignition and incompatible materials such as strong oxidizers. Ensure appropriate chemical labeling and access is restricted to trained personnel. |
Applications of 3-Methyl(E)-7-[3-(4-Fluorophenyl)-1-Methylethyl-Indol-2-Yl]-3-Hydroxy-5-Oxohept-6-Enoate in Industrial ManufacturingThis advanced indole-derived intermediate serves as a critical raw material for several specialized manufacturing sectors. Our chemical plays integral roles in active pharmaceutical ingredient (API) synthesis, specialty pesticide development, advanced materials engineering, and fine chemical manufacturing. Detailed below are the principal application scenarios, addressing usage specifications, compliance matters, integration points, and primary finished products seen by industrial buyers worldwide. 1. Active Pharmaceutical Ingredient Synthesis – Oncology Drug DevelopmentMany pharmaceutical manufacturers employ this compound as a core intermediate in the multi-step synthesis of targeted oncology therapeutics, particularly those involving indole or fluorophenyl scaffolds. Synthetic chemists introduce this material downstream after the initial building block assembly but prior to final amide coupling or salt formation stages. Its unique structure supports precise modifications of the API’s pharmacophore region, directly impacting the activity and selectivity profile mandated by preclinical and clinical programs targeting cancer treatments. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Research-Grade Specialty Pesticide SynthesisThe compound supports agrochemical innovators producing next-generation specialty pesticides with indole-derived bioactivity. Manufacturers source this chemical for use at the intermediate condensation and oxidation steps inherent to synthesizing selective hormone mimics and novel insecticidal active ingredients. The raw material’s substitution pattern enables fine-tuning of physiochemical and biological properties required for registration and field performance trials. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. OLED and Organic Electronic Material ManufacturingAdvanced materials manufacturers utilize this molecule as a precursor for synthesizing indole-based conjugated systems, which function as blue and green emitting layers in high-brightness OLED and organic electronic devices. The compound enters the process after halogenation and before metal-organic complexation, providing an essential backbone for fine-tuning electronic and photophysical characteristics crucial for device performance, lifetime, and efficiency metrics. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Advanced Fine Chemical and Dye Intermediate ProductionFine chemical producers value this high-purity indole derivative as a building block in the synthesis of specialty dyes and advanced chromophores designed for analytical, diagnostic, and industrial coloration applications. The compound is charged post-initial cyclization but before cross-coupling steps, offering manufacturers the opportunity to manipulate chromophore absorption and emission ranges or introduce fluorinated functionalities tailored to downstream customer performance specifications. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive 3-Methyl(E)-7-[3-(4-Fluorophenyl)-1-Methylethyl-Indol-2-Yl]-3-Hydroxy-5-Oxohept-6-Enoate prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Real progress in synthesis often relies on thoughtful design, resilience during scale-up, and a keen understanding of molecular uniqueness. Over the last decade in our production floors, one compound that has shaped research collaborations is 3-Methyl(E)-7-[3-(4-Fluorophenyl)-1-Methylethyl-Indol-2-Yl]-3-Hydroxy-5-Oxohept-6-Enoate. Manufacturing this substance in-house requires the sort of hands-on attention many overlook until they realize batch inconsistencies can derail downstream work for weeks. Researchers targeting specialized pharmacophores quickly recognize strong candidates. This hydroxy-oxoheptenoate variant stands out for its robust structure and practical reactivity under diverse conditions. Chemists across pharmaceutical, agrochemical, and material science sectors reach for this molecule because reliable consistency pays dividends in both time and outcomes.
Producing multifunctional indole derivatives is no simple feat. The main difference between handling this complex ester in-house and relying on intermediaries comes from process control and traceability. Small adjustments in precursor quality or reaction timing can tilt yields and influence critical impurity levels. Having experienced syntheses from pilot-scale stirring tanks to full-volume reactors, we value transparency above all else—specific gravity shifts, odor nuances, subtle tints in filtration—notes that often signal yield, purity, or safety implications. Purity cannot be left to chance. Monitoring batch histories, cleaning cycles, and routine spectral checks forms the baseline, not the exception. Direct control yields a degree of certainty that trickles down to our collaborators, letting them focus on discovery with fewer interruptions.
Our 3-Methyl(E)-7-[3-(4-Fluorophenyl)-1-Methylethyl-Indol-2-Yl]-3-Hydroxy-5-Oxohept-6-Enoate always comes matched to internally validated reference standards. There are few shortcuts in establishing tight analytical parameters. Every lot sees LC-MS, NMR, and FT-IR to confirm both purity and structural fidelity—the backbone of reliable research conclusions and scalable formulation. We lock in balanced moisture content, tailored particle sizing, and color as part of each lot’s protocol. Dense documentation about melting behavior, optical rotation, and known minor impurities gets delivered with every shipment. This approach arose not from regulation but from seeing how even minor mishandling during transport or storage can alter thermal properties or catalyze damaging reactions.
The stories from our customers often expand our own vision of use cases. Some discovery labs approached us searching for advanced building blocks for kinase inhibitor programs, others for rare disease pipelines. One customer described using our product to synthesize a promising lead in their neural receptor modulator series, noting that our batch provided greater reaction yields and cleaner chromatographic profiles compared to previous suppliers. Another team focused on crop science described its ease of modification for pesticide selectivity programs. This diversity emerged from hands-on learning during actual process scale-ups—not just literature reviews or theoretical possibilities.
We have seen a fair share of “equivalent” compounds claimed by resellers. More often than not, subtle synthesis differences create challenges. Our lots retain a consistent isomeric ratio, confirmed over hundreds of kilo-scale batches, rather than just small R&D trials. The indole backbone, combined with the para-fluorophenyl substituent, creates a unique interplay—particularly in complex multi-step reactions. We have tracked fragmentation patterns and degradation pathways across varying storage times and temperatures because our internal teams rely on these findings to predict batch behavior over time. Most supply chain disruptions we’ve witnessed stem from missing these deep details. It’s one thing to hit a purity spec, but quite another to ensure the subtlest impurities never fluctuate lot-to-lot.
Let’s set aside the catalog jargon. Building this molecule at scale, we’ve run into the full spectrum of production realities—oxidation risks, incomplete ring closures, lingering trace halides. Each lot reminds us that chemistry on paper only goes so far without real-world testing. We implemented dual-hemisphere storage before shipping to different climates, added real-time stability monitoring, instituted redundant filtration, and adopted extra safety controls on exothermic steps. Heat gradients in larger reactors require careful adjustment compared to small-scale syntheses. Stirring speeds, order of reagent addition, and even glassware cleaning solvent carryover have left their mark, so no batch escapes a full battery of internal checks.
Fast feedback from seasoned researchers has shaped how we optimize manufacture. Our team fields questions about solubility profiles in emerging solvents, requests for ultra-low impurity versions, or custom particle sizing for formulation studies. Each conversation deepens our appreciation for how unexpected workflow decisions—switching a reactor lining, updating raw material vendors—can impact customers downstream. Partnership with research teams running animal models or cell-based screens means we see first-hand which formulation quirks matter. The compound’s unusually stable enone structure aids both long-term stockpiling and rapid scale-up, opening doors for researchers on tight timelines.
Too many procurement officers have learned hard lessons from resellers who offer little visibility into lot divergences or shipping mishaps. By keeping production under one roof, our chemists tag every lot with a traceable batch record that logs yields, raw material lots, pressure readings, and even operator notes. Equipment, temperature, and even humidity during synthesis are tracked, particularly during seasons of high variance. This attention to record-keeping allows us to trace outlier events, retrace synthesis at customer request, and guarantee proper root cause analysis. We answer every incoming technical question with direct lab data, not canned responses. These practices grow from years of troubleshooting real incidents, not bureaucratic routines.
A few years ago, a prominent lab flagged an unexpected impurity in their final product that tracked back to our intermediate. Within days, our review of batch records pinpointed a reagent grade variation that had slipped into a single production window. We isolated affected lots, ran re-analysis, and provided a corrective protocol, preventing larger downstream losses. This sort of root-cause iteration never succeeds when intermediaries remove themselves from hands-on production. Our proximity to each step keeps learning loops short and supports continuous improvement.
Some clients ask for scale-up lots for late-stage synthesis validations, others for small trial quantities during screening. Both groups benefit from a close relationship with the production chemists who understand the nuanced interaction between reaction conditions and product outcomes. Many projects involve custom pH buffering, novel solvent systems, or unique crystallization techniques. With new medical applications on the rise, batches sometimes need purification tweaks to eliminate trace organohalide residues, minimize peroxide formation, or recapture minor side products for green chemistry studies. A distant trader can’t support these requests with the same empirical knowledge.
New chemical entities introduce challenging variables at almost every step. Slight deviations in chiral purity, melting range, or residual solvent content may slip past broad specifications, but in practice, they can kill costly programs. By keeping records down to the operator and tank level, and backing every shipment with internal lab spectra, we give formulation teams the confidence that each new bottle won’t break an established protocol. For example, teams designing solid-dosage forms rely on steady particle-size distributions to prevent unexpected blend segregation during tableting. Formulation breakdowns often surface only after weeks of costly in-process work, and restoring consistency eats budgets quickly.
Through running over a thousand batches, we mapped out specific impurity patterns that only appear with certain temperature plateaus or excess driving reagents. A controlled temperature ramp reveals small differences in isomeric content that don’t show in ambient synthesis. Subtle process tweaks—like modulating agitation rates—produced cleaner products reproducibly. Once, an unexpected byproduct turned out to offer valuable insights: a minor indole dimerization provided a new route for side-project analogs and activity probes. None of this insight emerges without direct, daily engagement across the plant floor and at the lab bench.
One often-cited concern revolves around shelf life and real shipping scenarios. We designed packaging protocols for both frigid winter freight and humid monsoon climates. Thermal insulation wasn’t enough; fielded tests required custom desiccant systems and secondary containment after early customer reports. A direct manufacturer never outsources this learning, instead building feedback from actual delivery outcomes back into the process. Workflows get refined so the product always arrives with its spectral signature intact, regardless of journey length.
Large-scale manufacture brings regulatory and eco-conscious demands to the foreground. Production of this molecule means continuous waste minimization studies, targeted air-handling improvements, and live monitoring for volatile byproducts. In our experience, real progress comes from iterative safety reviews based on up-to-date incident histories. We invested in reactor headspace monitoring and internal containment checks, after learning that even trace halide emissions scaled up far faster than predicted in late-stage development. Years of firsthand hazard assessments translate into safer environments for both staff and partners. All outputs comply with prevailing industry standards for emissions and waste disposal.
Demand ebbs and flows in cycles, not always following predictable curves. Researchers might learn they need a higher-purity lot after an unexpected animal toxicity signal, or a shorter lead time for a last-minute grant extension. Tight feedback loops support flexible response to such shifts. We have added dedicated production blocks for fast-turnaround projects upon request, providing real-time order status and production tracking to keep everyone in the loop. Close conversation with scientific buyers uncovers novel technical requirements. A batch destined for an oncology project gets run with extra monitoring for metallic impurities; another for material science gains custom crystallization to improve surface properties.
Being on the manufacturing side means each challenge expands our range of expertise. Custom syntheses based on modifications of this backbone arise with increasing frequency. Newer analogs require adaption of solvent systems, temporizing vesicles during sensitive steps, or careful addition schemes. By collaborating directly with innovators, we cut down on the lag time between discovery and delivery. Internal R&D teams keep the core process evolving; input from users routinely reveals unforeseen avenues for further optimization—turning a synthesis hiccup into a springboard for better design.
Lessons from the shop floor set the foundation for enduring trust. Each batch, every minor deviation, routine or not, becomes a datapoint for further improvement. We draw on the wealth of experience from handling setbacks in real time—not revising narratives, but responding with evidence, fully tracked and shared. From the earliest reactor crackle on heating, to final sealed bottle before shipment, every step stays within our oversight. The only guarantee that matters in research supply chains comes from producers who disclose their own learning. Synthetic chemistry rewards this transparency, promoting progress far beyond the original catalog page. That is the difference direct manufacture delivers, batch after batch.